Това обаче води само до двукратно повишение на общата експозиция на метилналтрексон (AUC).
Severe renal impairment decreased the renal clearance of methylnaltrexone by 8- to 9-fold; however, this resulted in only a 2-fold increase in total methylnaltrexone exposure (AUC).